Literature DB >> 1868279

Residential therapeutic communities for female substance abusers.

G De Leon1, N Jainchill.   

Abstract

Therapeutic communities provide a unique model for the needs of chemically dependent mothers who are pregnant or of child bearing age. These programs have been treating female addicts, many of whom reflect the profile and needs of the current generation of addicted mothers in clinical problems, social disadvantages, and poor socialization. Specific issues of their recovery can be most efficiently addressed in a residential community that provides housing and a comprehensive approach including medical, social, psychological care, parental training, and child care. Most evident is that these women need a lifestyle change, an opportunity for maturation. In this regard, the therapeutic community offers the essential element of community as a setting for learning right living.

Entities:  

Mesh:

Year:  1991        PMID: 1868279      PMCID: PMC1807937     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


  12 in total

1.  Phoenix House: psychopathological signs among male and female drug-free residents.

Authors:  G De Leon
Journal:  Addict Dis       Date:  1974

2.  Therapeutic communities: what are the retention rates?

Authors:  G De Leon; S Schwartz
Journal:  Am J Drug Alcohol Abuse       Date:  1984       Impact factor: 3.829

3.  Women in drug abuse treatment programs: factors that influence retention at very early and later stages in two treatment modalities. A summary.

Authors:  R Moise; B G Reed; C Conell
Journal:  Int J Addict       Date:  1981-10

4.  Assessment of treatment outcomes in a drug abuse rehabilitation network: Newark, New Jersey.

Authors:  A M Sheffet; M A Quinones; K M Doyle; M A Lavenhar; A E Nakah; D B Louria
Journal:  Am J Drug Alcohol Abuse       Date:  1980       Impact factor: 3.829

Review 5.  Psychopathology and substance abuse: what is being learned from research in therapeutic communities.

Authors:  G De Leon
Journal:  J Psychoactive Drugs       Date:  1989 Apr-Jun

Review 6.  The therapeutic community: status and evolution.

Authors:  G De Leon
Journal:  Int J Addict       Date:  1985 Jun-Jul

Review 7.  Female clients in substance abuse treatment.

Authors:  J C Marsh; N A Miller
Journal:  Int J Addict       Date:  1985 Jun-Jul

8.  Cocaine use in pregnancy.

Authors:  I J Chasnoff; W J Burns; S H Schnoll; K A Burns
Journal:  N Engl J Med       Date:  1985-09-12       Impact factor: 91.245

9.  Women residents: expanding their role to increase treatment effectiveness in substance abuse programs.

Authors:  S Stevens; N Arbiter; P Glider
Journal:  Int J Addict       Date:  1989-05
View more
  5 in total

1.  Substance use during pregnancy: time for policy to catch up with research.

Authors:  Barry M Lester; Lynne Andreozzi; Lindsey Appiah
Journal:  Harm Reduct J       Date:  2004-04-20

2.  Reframing the debate: toward effective treatment for inner city drug-abusing mothers.

Authors:  W Chavkin; D Paone; P Friedmann; I Wilets
Journal:  Bull N Y Acad Med       Date:  1993

3.  Women in jail: is substance abuse treatment enough?

Authors:  S A Alemagno
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

4.  Psychopathology and treatment outcome of drug dependent women in a perinatal program.

Authors:  Karen S Ingersoll; Janet S Knisely; Kathryn S Dawson; Sidney H Schnoll
Journal:  Addict Behav       Date:  2004-06       Impact factor: 3.913

Review 5.  Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.

Authors:  Barbara K Zedler; Ashley L Mann; Mimi M Kim; Halle R Amick; Andrew R Joyce; E Lenn Murrelle; Hendrée E Jones
Journal:  Addiction       Date:  2016-06-30       Impact factor: 6.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.